Patents by Inventor Marcia Angela Van Valen

Marcia Angela Van Valen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8603079
    Abstract: A method for treating presbyopia utilizes an Erbium based, pulsed laser to sever sub-conjunctival strictures located within the scleral matrix of the eye. Introduction of treatment energy into the scleral matrix increases or facilitates an increase in accommodation, thereby mitigating the effects of presbyopia. The treatment energy can be directed into the scleral matrix to form tunnel ablations in and through the strictures of the scleral matrix. The tunnel ablations can enhance the accommodation of the patient's eye, enabling the eye to refocus at near distances while not losing its ability to focus at a distance.
    Type: Grant
    Filed: February 1, 2013
    Date of Patent: December 10, 2013
    Assignee: Biolase, Inc.
    Inventor: Marcia Angela Van Valen
  • Patent number: 8602033
    Abstract: Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.
    Type: Grant
    Filed: January 19, 2011
    Date of Patent: December 10, 2013
    Assignee: Biolase, Inc.
    Inventors: Jeffrey W. Jones, Marcia Angela Van Valen
  • Patent number: 8568392
    Abstract: Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.
    Type: Grant
    Filed: October 29, 2007
    Date of Patent: October 29, 2013
    Assignee: Biolase, Inc.
    Inventors: Jeffrey W. Jones, Marcia Angela Van Valen
  • Patent number: 8448645
    Abstract: Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.
    Type: Grant
    Filed: June 27, 2011
    Date of Patent: May 28, 2013
    Assignee: Biolase, Inc.
    Inventors: Jeffrey W. Jones, Marcia Angela Van Valen
  • Patent number: 8366702
    Abstract: A method for treating presbyopia utilizes an Erbium based, pulsed laser to sever sub-conjunctival strictures located within the scleral matrix of the eye. Introduction of treatment energy into the scleral matrix increases or facilitates an increase in accommodation, thereby mitigating the effects of presbyopia. The treatment energy can be directed into the scleral matrix to form tunnel ablations in and through the strictures of the scleral matrix. The tunnel ablations can enhance the accommodation of the patient's eye, enabling the eye to refocus at near distances while not losing its ability to focus at a distance.
    Type: Grant
    Filed: December 21, 2010
    Date of Patent: February 5, 2013
    Assignee: Biolase, Inc.
    Inventor: Marcia Angela Van Valen
  • Patent number: 8276593
    Abstract: Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.
    Type: Grant
    Filed: March 22, 2011
    Date of Patent: October 2, 2012
    Assignee: BIOLASE, Inc.
    Inventors: Jeffrey W. Jones, Marcia Angela Van Valen
  • Patent number: 8256431
    Abstract: A method for treating presbyopia utilizes an Erbium based, pulsed laser to sever sub-conjunctival strictures located within the scleral matrix of the eye. Introduction of treatment energy into the scleral matrix increases or facilitates an increase in accommodation, thereby mitigating the effects of presbyopia. The treatment energy can be directed into the scleral matrix to form tunnel ablations in and through the strictures of the scleral matrix. The tunnel ablations can enhance the accommodation of the patient's eye, enabling the eye to refocus at near distances while not losing its ability to focus at a distance.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: September 4, 2012
    Assignee: BIOLASE, Inc.
    Inventor: Marcia Angela Van Valen
  • Patent number: 8056564
    Abstract: Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.
    Type: Grant
    Filed: November 3, 2008
    Date of Patent: November 15, 2011
    Assignee: Biolase Technology, Inc.
    Inventors: Jeffrey W. Jones, Marcia Angela Van Valen
  • Publication number: 20110257639
    Abstract: Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.
    Type: Application
    Filed: June 27, 2011
    Publication date: October 20, 2011
    Inventors: Jeffrey W. Jones, Marcia Angela Van Valen
  • Patent number: 7997279
    Abstract: Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.
    Type: Grant
    Filed: November 3, 2008
    Date of Patent: August 16, 2011
    Assignee: Biolase Technology, Inc.
    Inventors: Jeffrey W. Jones, Marcia Angela Van Valen
  • Publication number: 20110192405
    Abstract: Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.
    Type: Application
    Filed: January 19, 2011
    Publication date: August 11, 2011
    Inventors: Jeffrey W. Jones, Marcia Angela Van Valen
  • Publication number: 20110172650
    Abstract: Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.
    Type: Application
    Filed: March 22, 2011
    Publication date: July 14, 2011
    Inventors: Jeffrey W. Jones, Marcia Angela Van Valen
  • Patent number: 7967017
    Abstract: Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.
    Type: Grant
    Filed: October 17, 2007
    Date of Patent: June 28, 2011
    Assignee: Biolase Technology, Inc.
    Inventors: Jeffrey W. Jones, Marcia Angela Van Valen
  • Publication number: 20110092964
    Abstract: A method for treating presbyopia utilizes an Erbium based, pulsed laser to sever sub-conjunctival strictures located within the scleral matrix of the eye. Introduction of treatment energy into the scleral matrix increases or facilitates an increase in accommodation, thereby mitigating the effects of presbyopia. The treatment energy can be directed into the scleral matrix to form tunnel ablations in and through the strictures of the scleral matrix. The tunnel ablations can enhance the accommodation of the patient's eye, enabling the eye to refocus at near distances while not losing its ability to focus at a distance.
    Type: Application
    Filed: December 21, 2010
    Publication date: April 21, 2011
    Inventor: Marcia Angela Van Valen
  • Patent number: 7909040
    Abstract: Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.
    Type: Grant
    Filed: October 4, 2007
    Date of Patent: March 22, 2011
    Assignee: Biolase Technology, Inc.
    Inventors: Jeffrey W. Jones, Marcia Angela Van Valen
  • Patent number: 7891363
    Abstract: Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.
    Type: Grant
    Filed: October 29, 2007
    Date of Patent: February 22, 2011
    Assignee: Biolase Technology, Inc.
    Inventors: Jeffrey W. Jones, Marcia Angela Van Valen
  • Patent number: 7878204
    Abstract: A method for treating presbyopia utilizes an Erbium based, pulsed laser to sever sub-conjunctival strictures located within the scleral matrix of the eye. Introduction of treatment energy into the scleral matrix increases or facilitates an increase in accommodation, thereby mitigating the effects of presbyopia. The treatment energy can be directed into the scleral matrix to form tunnel ablations in and through the strictures of the scleral matrix. The tunnel ablations can enhance the accommodation of the patient's eye, enabling the eye to refocus at near distances while not losing its ability to focus at a distance.
    Type: Grant
    Filed: April 24, 2006
    Date of Patent: February 1, 2011
    Assignee: Biolase Technology, Inc.
    Inventor: Marcia Angela Van Valen
  • Patent number: 7867223
    Abstract: A method for treating presbyopia utilizes an Erbium based, pulsed laser to sever sub-conjunctival strictures located within the scleral matrix of the eye. Introduction of treatment energy into the scleral matrix increases or facilitates an increase in accommodation, thereby mitigating the effects of presbyopia. The treatment energy can be directed into the scleral matrix to form tunnel ablations in and through the strictures of the scleral matrix. The tunnel ablations can enhance the accommodation of the patient's eye, enabling the eye to refocus at near distances while not losing its ability to focus at a distance.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: January 11, 2011
    Assignee: Biolase Technology, Inc.
    Inventor: Marcia Angela Van Valen
  • Patent number: 7665467
    Abstract: Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.
    Type: Grant
    Filed: April 26, 2006
    Date of Patent: February 23, 2010
    Assignee: Biolase Technology, Inc.
    Inventors: Jeffrey W. Jones, Marcia Angela Van Valen
  • Publication number: 20090118719
    Abstract: Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.
    Type: Application
    Filed: November 3, 2008
    Publication date: May 7, 2009
    Inventors: Jeffrey W. Jones, Marcia Angela Van Valen